Royce & Associates LP boosted its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 2.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 758,068 shares of the company's stock after buying an additional 18,091 shares during the quarter. Royce & Associates LP owned approximately 1.66% of Azenta worth $37,903,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of AZTA. State Street Corp boosted its position in Azenta by 0.4% during the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company's stock valued at $81,718,000 after acquiring an additional 6,398 shares in the last quarter. Conestoga Capital Advisors LLC boosted its position in Azenta by 65.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock valued at $78,894,000 after purchasing an additional 621,830 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in Azenta by 1.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock valued at $65,922,000 after purchasing an additional 18,529 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in Azenta by 11.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 461,603 shares of the company's stock valued at $23,080,000 after purchasing an additional 48,064 shares during the last quarter. Finally, Systematic Financial Management LP raised its holdings in Azenta by 8.7% in the third quarter. Systematic Financial Management LP now owns 434,597 shares of the company's stock worth $21,052,000 after purchasing an additional 34,849 shares in the last quarter. Institutional investors own 99.08% of the company's stock.
Azenta Stock Performance
AZTA stock traded up $1.01 during trading on Thursday, reaching $37.79. The company had a trading volume of 633,448 shares, compared to its average volume of 582,551. Azenta, Inc. has a twelve month low of $35.56 and a twelve month high of $63.58. The company has a market cap of $1.73 billion, a price-to-earnings ratio of -12.68 and a beta of 1.52. The firm has a 50-day simple moving average of $47.27 and a 200-day simple moving average of $46.79.
Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Sell-side analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on AZTA shares. Evercore ISI raised their price target on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Needham & Company LLC raised their target price on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. TD Cowen raised Azenta to a "hold" rating in a research report on Thursday, February 27th. Finally, Stephens reissued an "overweight" rating and issued a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $58.75.
Read Our Latest Stock Report on Azenta
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
